GlassScriptPhysician profile
Robert L Fiorelli
NPI 1568463784
$7,088.72
in general payments reported to CMS, 2019-2025
33 companies · $1,724 in 2025
The $1,724 reported for 2025 was more than what 76% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $652 · 2020: $805 · 2021: $771 · 2022: $664 · 2023: $1,192 · 2024: $1,281 · 2025: $1,724.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,196.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $996.55 | 2019-2025 | Xtandi |
| Axonics, INC. | $854.96 | 2020-2024 | Axonics, Bulkamid |
| Sumitomo Pharma America, INC. | $808.17 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $797.98 | 2019-2025 | Erleada, Akeega, Balversa |
| Bayer Healthcare Pharmaceuticals INC. | $749.96 | 2019-2025 | |
| Abbvie INC. | $746.28 | 2019-2025 | |
| Pfizer INC. | $510.84 | 2019-2025 | |
| Medtronic, INC. | $263.98 | 2023-2025 | Symplicity G3, Interstim |
| Urogen Pharma, INC. | $160.23 | 2021-2025 | Jelmyto |
| Actelion Pharmaceuticals US, INC. | $122.09 | 2025 | Uptravi, Opsumit |
| Laborie Medical Technologies Corp. | $111.08 | 2023-2024 | Optilume Bph Drug Coated Balloon Catheter |
| 180 Medical, INC. | $102.54 | 2023-2024 | Gentlecath |
| Merck Sharp & Dohme LLC | $94.33 | 2023-2025 | Keytruda, Lynparza |
| Antares Pharma, INC. | $79.37 | 2020-2024 | Xyosted |
| Telix Pharmaceuticals | $62.84 | 2025 | Illuccix |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $60.09 | 2019-2025 | |
| Olympus America INC. | $59.51 | 2022-2025 | Bovie |
| Kowa Pharmaceuticals America, INC. | $57.14 | 2023 | Seglentis |
| Novartis Pharmaceuticals Corporation | $55.19 | 2023-2025 | |
| Dentsply Ih Ab | $48.48 | 2024 | Lofric |
| Urovant Sciences INC | $48.17 | 2021-2022 | |
| Teleflex LLC | $44.69 | 2021-2023 | Urolift |
| Ferring Pharmaceuticals INC. | $37.49 | 2019-2025 | Adstiladrin |
| Allergan, INC. | $30.15 | 2019-2020 | |
| Progenics Pharmaceuticals, INC. | $27.55 | 2023-2024 | Pylarify |
| Stryker Corporation | $27.50 | 2024 | Mild Device Kit |
| Convatec INC. | $27.19 | 2023 | |
| Halozyme INC | $26.53 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $18.88 | 2024 | Exparel |
| Myovant Sciences INC. | $18.15 | 2022 | |
| Cook Medical LLC | $17.03 | 2023 | Cook |
| Medtronic USA, INC. | $12.22 | 2020 | |
| Boston Scientific Corporation | $11.56 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Fiorelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.